Systemic Aging & Blood Rejuvenation Lab

MIT Tech Review Analysis • SASP Contagion vs RCT Rigor

Microvascular Organ Network & Paracrine Contagion Live D3 Vascular Map

185.4 pg/mL

Biomarker Telemetry & Endpoint Gaps

Circulating SASP Reduction
58.6 %
Simulated Epigenetic Age Shift
-4.2 yrs
Tissue Recovery Index
0.74 / 1.00
Evidentiary Rigor Level
Tier 3
Evidentiary Red Flag: Lacks randomized placebo-controlled clinical outcome endpoints. Surrogate methylation clocks (Horvath/GrimAge) often shift with transient hydration or inflammation without translating into preserved organ reserve or extended functional lifespan.

Evidentiary Matrix: Startup Pilot vs FDA RCT Gold Standard

Evaluation Criterion Generation Lab / Pilot Gold Standard RCT
Cohort Control Single-Arm / Influencers Double-Blind Placebo
Primary Endpoint Surrogate DNAm Clocks Hard Organ Failure / VO2 Max
Systemic SASP Validation Blood Serum Multiplex Multi-Tissue Biopsy Clearance
Placebo Effect Isolation Uncontrolled / Open-Label Pre-registered Mock Infusion
Inspired by MIT Technology Review investigation on blood rejuvenation startups, parabiosis mechanisms, and surrogate biomarker validity.
Super generates helpful tools and automates fact-checking across the internet proactively. If you enjoyed this tool, build your own with Super and share it with a friend.